Please ensure Javascript is enabled for purposes of website accessibility

Anthem Posts Mixed Q1 Results but Gives Upbeat Guidance

By Keith Speights - Updated Apr 21, 2021 at 10:03AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The health insurance giant continued to feel the impact of COVID-19 in the first quarter.

Anthem (ANTM 2.71%) is a good example of the market rotation away from high-growth stocks. Shares of the big health insurer rose only 6% in 2020 but are up nearly 19% so far this year -- with most of the gain coming since March.

The company announced its first-quarter results before the market open on Wednesday. The health insurance stock rose slightly in early trading. Here are the highlights from Anthem's Q1 update.

Client signing up for health insurance.

Image source: Getty Images.

By the numbers

Anthem reported revenue in the first quarter of $32.4 billion. This reflected a 9% increase from the prior-year period revenue total of $29.6 billion. However, it fell short of the consensus Wall Street revenue estimate of $32.9 billion.

The company reported net income in the first quarter of $1.7 billion, or $6.71 per share, based on generally accepted accounting principles (GAAP). In the prior-year period, Anthem's GAAP earnings totaled $1.5 billion, or $5.94 per share.

There was also solid improvement with Anthem's bottom line on a non-GAAP basis. The health insurance giant posted adjusted net income in the first quarter of $1.74 billion, or $7.01 per share, compared to adjusted earnings of $1.66 billion, or $6.48 per share, in the prior-year period. Anthem's Q1 adjusted earnings easily topped the average analysts' estimate of $6.51 per share.

Behind the numbers

The COVID-19 pandemic continued to weigh on Anthem's health insurance business. The company reported an operating gain of nearly $1.27 billion for its commercial & specialty business segment, down from $1.42 billion in the prior-year period. Higher costs related to COVID-19 testing and vaccine administration served as the primary factor behind this decline.

Its government business segment's operating gain jumped 16.3% year over year to $478 million in Q1. Medicaid membership growth was the key driver behind this increase. It also helped that there was one less calendar day in the first quarter of 2021 than in the prior-year period. However, increased COVID-19-related costs, along with Medicaid rebates and lower risk-based revenue, held back government business growth to some extent.

Anthem's IngenioRx pharmacy benefits management (PBM) business posted an operating gain of $407 million in Q1, up 16.6% year over year. The company attributed this increase to an out-of-period adjustment and growth in its integrated medical and pharmacy membership.

Looking ahead

Anthem projects that its full-year 2021 operating revenue will be around $135.1 billion, in line with the consensus Wall Street estimate. This total includes expected premium revenue between $114.5 billion and $115.5 billion. It anticipates GAAP net income of more than $24.05 per share with adjusted earnings greater than $25.10 per share -- higher than what analysts were projecting.

The company remains the second-largest health insurer in the U.S. based on market share, ranking behind only UnitedHealth Group. Anthem doesn't have all of the businesses that UnitedHealth has with its Optum unit, though, which helped boost UnitedHealth's growth in its first quarter.

However, Anthem CEO Gail Boudreaux likes her company's prospects. "We expect the positive momentum in the first quarter to persist through the balance of the year," she said. "I am confident that we are well positioned to capitalize on future opportunities for growth." 

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Anthem, Inc. Stock Quote
Anthem, Inc.
$482.58 (2.71%) $12.71
UnitedHealth Group Incorporated Stock Quote
UnitedHealth Group Incorporated
$517.40 (0.73%) $3.77

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/02/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.